Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF-Reference-Cited by-同舟云学术

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

Published:2015-04-24 Issue:7-8 Volume:9 Page:715-731
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Spellman Daniel S.¹,Wildsmith Kristin R.²,Honigberg Lee A.²,Tuefferd Marianne³,Baker David⁴,Raghavan Nandini⁴,Nairn Angus C.⁵,Croteau Pascal⁶,Schirm Michael⁶,Allard Rene⁶,Lamontagne Julie⁶,Chelsky Daniel⁶,Hoffmann Steven⁷,Potter William Z.⁸, ,

Affiliation:

1. Department of Pharmacokinetics; Pharmacodynamics and Drug Metabolism; Merck Research Laboratories; Pennsylvania PA USA

2. Department of Pharmacodynamic Biomarkers within Development Sciences, Genentech, Inc (a member of the Roche Group); South San Francisco CA USA

3. Discovery Sciences; Janssen Research & Development LLC; Pharmaceutical Companies of Johnson & Johnson; Beerse Belgium

4. Janssen Research & Development LLC; Titusville NJ USA

5. Department of Psychiatry; Yale University School of Medicine; New Haven CT USA

6. Caprion Pharmaceuticals; Montreal QC Canada

7. Foundation for the National Institutes of Health, Inc; Bethesda MD USA

8. National Institute of Mental Health; Bethesda MD USA

Publisher

Wiley

Subject

Clinical Biochemistry

Reference62 articles.

1. Depression in informal caregivers of persons with dementia;D'Aoust;Int. J. Older People Nurs.,2015

2. An exploratory study of grief and health-related quality of life for caregivers of people with dementia;Shuter;Am. J. Alzheimers Dis. Other Demen.,2013

3. National estimates of the prevalence of Alzheimer's disease in the United States;Brookmeyer;Alzheimers Dement.,2011

4. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease;Fagan;Biomark. Med.,2012

5. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease;McKhann;Neurology,1984

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker-Based Precision Therapy for Alzheimer’s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine;Journal of Clinical Medicine;2024-08-08

2. Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease;Alzheimer's & Dementia;2024-07-28

3. Plasma pTau181 enhances the prediction of future clinical decline in amyloid‐positive mild cognitive impairment;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-07

4. Development of highly multiplex targeted proteomics assays in biofluids using the Stellar mass spectrometer;2024-06-05

5. Data Independent Acquisition to Inform the Development of Targeted Proteomics Assays Using a Triple Quadrupole Mass Spectrometer;2024-05-31